2-98391964-C-T
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM5PP2PP3_StrongPP5_Very_Strong
The NM_001298.3(CNGA3):c.667C>T(p.Arg223Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000131 in 1,613,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R223Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001298.3 missense
Scores
Clinical Significance
Conservation
Publications
- achromatopsia 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Illumina, PanelApp Australia
- CNGA3-related retinopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- achromatopsiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CNGA3 | ENST00000272602.7 | c.667C>T | p.Arg223Trp | missense_variant | Exon 7 of 8 | 1 | NM_001298.3 | ENSP00000272602.2 | ||
| CNGA3 | ENST00000436404.6 | c.613C>T | p.Arg205Trp | missense_variant | Exon 6 of 7 | 1 | ENSP00000410070.2 | |||
| CNGA3 | ENST00000409937.1 | n.820C>T | non_coding_transcript_exon_variant | Exon 7 of 8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152132Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000757 AC: 19AN: 251150 AF XY: 0.0000663 show subpopulations
GnomAD4 exome AF: 0.000137 AC: 200AN: 1461402Hom.: 0 Cov.: 31 AF XY: 0.000140 AC XY: 102AN XY: 727028 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74328 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Observed in homozygous state in patients with features of a CNGA3-related retinal dystrophy in the literature and not observed in homozygous state in controls (PMID: 11536077, 24903488); Published functional studies demonstrate a damaging effect (suggested loss of function of CNG channels) (PMID: 17693388); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24903488, 31964843, 36460718, 33562422, 35456422, 26992781, 23972307, 25283059, 18445228, 24793738, 15712225, 14757870, 17265047, 27040408, 28341476, 30418171, 27820752, 25168900, 24504161, 11536077, 17693388) -
- -
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 223 of the CNGA3 protein (p.Arg223Trp). This variant is present in population databases (rs138958917, gnomAD 0.02%). This missense change has been observed in individuals with achromatopsia (PMID: 11536077, 23972307). ClinVar contains an entry for this variant (Variation ID: 498768). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CNGA3 protein function. Experimental studies have shown that this missense change affects CNGA3 function (PMID: 17693388). This variant disrupts the p.Arg223 amino acid residue in CNGA3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 24504161, 24903488, 26992781; internal data). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Achromatopsia 2 Pathogenic:2
- -
- -
Achromatopsia Pathogenic:1
- -
CNGA3-related disorder Pathogenic:1
The CNGA3 c.667C>T variant is predicted to result in the amino acid substitution p.Arg223Trp. This variant has been reported in the homozygous and compound heterozygous states in individuals with achromatopsia (see for examples: Wissinger et al. 2001. PubMed ID: 11536077; Nishiguchi et al. 2005. PubMed ID: 15712225; Fahim et al. 2013. PubMed ID: 23972307; Lin et al. 2024. PubMed ID: 38219857). Alternate substitutions of this amino acid residue (p.Arg223Gly and p.Arg223Gln) have also been reported in individuals with achromatopsia (Table S2, Sharon et al. 2019. PubMed ID: 31456290; Table S1, Weisschuh et al. 2020. PubMed ID: 32531858). This variant is reported in 0.015% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Given the evidence, we interpret this variant as pathogenic. -
Retinal dystrophy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at